MRE11 as a Predictive Biomarker of Outcome After Radiation Therapy in Bladder Cancer.
International Journal of Radiation Oncology Biology Physics.
Times cited: 2
Clinical trial designs for rare diseases: Studies developed and discussed by the International Rare Cancers Initiative.
European Journal of Cancer.
Times cited: 61
Is high dose therapy superior to conventional dose therapy as initial treatment for relapsed germ cell tumors? The TIGER trial.
Journal of Cancer.
Times cited: 32